As of 2025-10-27, the EV/EBITDA ratio of Lineage Cell Therapeutics Inc (LCTX) is -13.42. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. LCTX's latest enterprise value is 388.21 mil USD. LCTX's TTM EBITDA according to its financial statements is -28.92 mil USD. Dividing these 2 quantities gives us the above LCTX EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |